Talk:Suresh Jadhav (biotechnology executive)
Latest comment: 2 years ago by Venkat TL in topic Development of Covishield?
 | A fact from this article appeared on Wikipedia's Main Page in the "Did you know?" column on December 23, 2021. The text of the entry was: Did you know ... that Suresh Jadhav led the development of the COVID-19 vaccine marketed as Covishield? |
 | A news item involving this article was featured on Wikipedia's Main Page in the "In the news" column on December 11, 2021. |
 | This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
.svg){kind=small} | Daily pageviews of this article
A graph should have been displayed here but graphs are temporarily disabled. Until they are enabled again, visit the interactive graph at pageviews.wmcloud.org |
 | It is requested that a photograph be included in this article to improve its quality.
The external tool WordPress Openverse may be able to locate suitable images on Flickr and other web sites. |
Development of Covishield? edit
The dyk said, " Suresh Jadhav led the development of the COVID-19 vaccine marketed as Covishield? "
Covishield redirects to Oxford–AstraZeneca COVID-19 vaccine, as covishield is the marketing name of the vaccine manufactured in India. It was developed by the team of Oxford and AstraZeneca. Jadhav was not a member of the development team of Oxford–AstraZeneca COVID-19 vaccine. @Gerda Arendt Why then was this misleading DYK allowed to run. The DYK should have said manfucturing instead of development. Deccan Herald seems to lack this basic understanding. Poor sourcing. Venkat TL (talk) 10:00, 30 December 2021 (UTC)